WHO. Obesity and overweight. (2024). https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Blüher, M. (2019). Obesity: global epidemiology and pathogenesis. Nature Reviews Endocrinology, 15, 288–298. https://doi.org/10.1038/s41574-019-0176-8.

Article  PubMed  Google Scholar 

Heymsfield, S. B., & Wadden, T. A. (2017). Mechanisms, Pathophysiology, and Management of Obesity. The New England Journal of Medicine, 376, 254–266. https://doi.org/10.1056/NEJMra1514009.

Article  CAS  PubMed  Google Scholar 

Akil, L., & Ahmad, H. A. (2011). Relationships between obesity and cardiovascular diseases in four southern states and Colorado. Journal of Health Care for the Poor and Underserved, 22, 61–72. https://doi.org/10.1353/hpu.2011.0166.

Article  PubMed  PubMed Central  Google Scholar 

Powell-Wiley, T. M., Poirier, P., Burke, L. E., Despres, J. P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., St-Onge, M. P., & American Heart Association Council on L, Cardiometabolic H, Council on C, Stroke N, Council on Clinical C, Council on E, Prevention and Stroke C. (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation, 143, e984–e1010. https://doi.org/10.1161/CIR.0000000000000973.

Article  PubMed  PubMed Central  Google Scholar 

Roomy, M. A., Hussain, K., Behbehani, H. M., Abu-Farha, J., Al-Harris, R., Ambi, A. M., Abdalla, M. A., Al-Mulla, F., Abu-Farha, M., & Abubaker, J. (2024). Therapeutic advances in obesity management: an overview of the therapeutic interventions. Front Endocrinol (Lausanne), 15, 1364503. https://doi.org/10.3389/fendo.2024.1364503.

Article  PubMed  Google Scholar 

Varady, K. A., Cienfuegos, S., Ezpeleta, M., & Gabel, K. (2022). Clinical application of intermittent fasting for weight loss: progress and future directions. Nature Reviews Endocrinology, 18, 309–321. https://doi.org/10.1038/s41574-022-00638-x.

Article  PubMed  Google Scholar 

Stockman, M. C., Thomas, D., Burke, J., & Apovian, C. M. (2018). Intermittent Fasting: Is the Wait Worth the Weight? Current Obesity Reports, 7, 172–185. https://doi.org/10.1007/s13679-018-0308-9.

Article  PubMed  PubMed Central  Google Scholar 

Malinowski, B., Zalewska, K., Wesierska, A., Sokolowska, M. M., Socha, M., Liczner, G., Pawlak-Osinska, K. & Wicinski, M. (2019) Intermittent Fasting in Cardiovascular Disorders-An Overview. Nutrients, 11. https://doi.org/10.3390/nu11030673

Feingold, K. R. (2000). Introduction to Lipids and Lipoproteins. In: Feingold, K. R., Anawalt, B., Blackman, M. R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W. W., Dhatariya, K., Dungan, K., Hofland, J., Kalra, S., Kaltsas, G., Kapoor, N., Koch, C., Kopp, P., Korbonits, M., Kovacs, C. S., Kuohung, W., Laferrere, B., Levy, M., McGee, E. A., McLachlan, R., New, M., Purnell, J., Sahay, R., Shah, A. S., Singer, F., Sperling, M. A., Stratakis, C. A., Trence, D. L., & Wilson, D. P. (Eds.) Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA).

Jomard, A., & Osto, E. (2019). Metabolism and Function of High-Density Lipoproteins (HDL). Praxis, 108, 477–486. https://doi.org/10.1024/1661-8157/a003241.

Thomas, S. R., Zhang, Y., & Rye, K. A. (2023). The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I. Best Practice and Research Clinical Endocrinology and Metabolism, 37, 101689 https://doi.org/10.1016/j.beem.2022.101689.

Article  CAS  PubMed  Google Scholar 

Chait, A., Ginsberg, H. N., Vaisar, T., Heinecke, J. W., Goldberg, I. J., & Bornfeldt, K. E. (2020). Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease. Diabetes, 69, 508–516. https://doi.org/10.2337/dbi19-0007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dallinga-Thie, G. M., Franssen, R., Mooij, H. L., Visser, M. E., Hassing, H. C., Peelman, F., Kastelein, J. J., Peterfy, M., & Nieuwdorp, M. (2010). The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis, 211, 1–8. https://doi.org/10.1016/j.atherosclerosis.2009.12.027.

Article  CAS  PubMed  Google Scholar 

Judge, A., & Dodd, M. S. (2020). Metabolism. Essays in Biochemistry, 64, 607–647. https://doi.org/10.1042/EBC20190041.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schumaker, V. N., & Adams, G. H. (1969). Circulating lipoproteins. Annual Review of Biochemistry, 38, 113–136. https://doi.org/10.1146/annurev.bi.38.070169.000553.

Article  CAS  PubMed  Google Scholar 

Campos, H., Genest, Jr, J. J., Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W., & Schaefer, E. J. (1992). Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis Thrombosis, 12, 187–195. https://doi.org/10.1161/01.atv.12.2.187.

Article  CAS  PubMed  Google Scholar 

Toth, P. P., Grabner, M., Punekar, R. S., Quimbo, R. A., Cziraky, M. J., & Jacobson, T. A. (2014). Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets. Atherosclerosis, 235, 585–591. https://doi.org/10.1016/j.atherosclerosis.2014.05.914.

Article  CAS  PubMed  Google Scholar 

Fernandez, C., Sandin, M., Sampaio, J. L., Almgren, P., Narkiewicz, K., Hoffmann, M., Hedner, T., Wahlstrand, B., Simons, K., Shevchenko, A., James, P., & Melander, O. (2013). Plasma lipid composition and risk of developing cardiovascular disease. PLoS One, 8, e71846 https://doi.org/10.1371/journal.pone.0071846.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Figorilli, F., Mannarino, M. R., Sahebkar, A., & Pirro, M. (2023). Lipid profile screening and ASCVD prevention. Expert Review of Cardiovascular Therapy, 21, 463–471. https://doi.org/10.1080/14779072.2023.2218087.

Article  CAS  PubMed  Google Scholar 

Bhutani, S., Klempel, M. C., Kroeger, C. M., Trepanowski, J. F., & Varady, K. A. (2013). Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring), 21, 1370–1379. https://doi.org/10.1002/oby.20353.

Article  CAS  PubMed  Google Scholar 

Tinsley, G. M., & La Bounty, P. M. (2015). Effects of intermittent fasting on body composition and clinical health markers in humans. Nutrition Reviews, 73, 661–674. https://doi.org/10.1093/nutrit/nuv041.

Article  PubMed  Google Scholar 

Meng, H., Zhu, L., Kord-Varkaneh, H., Heitor, O. S., Tinsley, G. M., & Fu, P. (2020). Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis. Nutrition, 77, 110801 https://doi.org/10.1016/j.nut.2020.110801.

Article  CAS  PubMed  Google Scholar 

Trepanowski, J. F., Kroeger, C. M., Barnosky, A., Klempel, M. C., Bhutani, S., Hoddy, K. K., Gabel, K., Freels, S., Rigdon, J., Rood, J., Ravussin, E., & Varady, K. A. (2017). Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Internal Medicine, 177, 930–938. https://doi.org/10.1001/jamainternmed.2017.0936.

Article  PubMed  PubMed Central  Google Scholar 

Mirmiran, P., Bahadoran, Z., Gaeini, Z., Moslehi, N., & Azizi, F. (2019). Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: An updated meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 29, 906–915. https://doi.org/10.1016/j.numecd.2019.05.056.

Article  CAS  PubMed  Google Scholar 

Zuo, L., He, F., Tinsley, G. M., Pannell, B. K., Ward, E., & Arciero, P. J. (2016). Comparison of High-Protein, Intermittent Fasting Low-Calorie Diet and Heart Healthy Diet for Vascular Health of the Obese. Frontiers in Physiology, 7, 350 https://doi.org/10.3389/fphys.2016.00350.

Article  PubMed  PubMed Central  Google Scholar 

Adlouni, A., Ghalim, N., Benslimane, A., Lecerf, J. M., & Saile, R. (1997). Fasting during Ramadan induces a marked increase in high-density lipoprotein cholesterol and decrease in low-density lipoprotein cholesterol. Annals of Nutrition and Metabolism, 41, 242–249. https://doi.org/10.1159/000177999.

Article  CAS  PubMed  Google Scholar 

Santos, H. O., & Macedo, R. C. O. (2018). Impact of intermittent fasting on the lipid profile: Assessment associated with diet and weight loss. Clinical nutrition ESPEN, 24, 14–21. https://doi.org/10.1016/j.clnesp.2018.01.002.

Article  PubMed  Google Scholar 

St-Onge, M. P., Ard, J., Baskin, M. L., Chiuve, S. E., Johnson, H. M., Kris-Etherton, P., Varady, K., & American Heart Association Obesity Committee of the Council on L, Cardiometabolic H, Council on Cardiovascular Disease in the Y, Council on Clinical C and Stroke C. (2017). Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation, 135, e96–e121. https://doi.org/10.1161/CIR.0000000000000476.

Article  PubMed  PubMed Central  Google Scholar 

Nawrocki, J. W., Weiss, S. R., Davidson, M. H., Sprecher, D. L., Schwartz, S. L., Lupien, P. J., Jones, P. H., Haber, H. E., & Black, D. M. (1995). Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 678–682. https://doi.org/10.1161/01.atv.15.5.678.

Article  CAS  PubMed